The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Columvi (glofitamab)
Australian Public Assessment Report
Device/Product Name
Columvi
Active ingredients
Glofitamab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-01989-1-6
Submission Type
New biological medicine
Decision
Approved